| |
| |
|
| Insider
Information: |
Roach James M. |
| Relationship: |
Senior VP, Development... |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
155,381 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$8,154,395 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
155,381 |
|
|
| Total
Value |
$8,154,395 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Momenta Pharmaceuticals Inc |
MNTA |
Senior VP, Development... |
2016-11-22 |
155,381 |
2009-02-25 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
97 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Development and Chi |
• – – |
2012-08-23 |
4 |
AS |
$13.64 |
$2,551 |
D/D |
(187) |
78,239 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Development and Chi |
• – – |
2012-11-26 |
4 |
AS |
$10.58 |
$1,989 |
D/D |
(188) |
77,666 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Development and Chi |
• – – |
2013-02-20 |
4 |
AS |
$12.62 |
$2,373 |
D/D |
(188) |
88,548 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Development and Chi |
• – – |
2012-05-23 |
4 |
AS |
$13.90 |
$2,627 |
D/D |
(189) |
78,811 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Development and Chi |
• – – |
2013-02-25 |
4 |
AS |
$12.43 |
$2,349 |
D/D |
(189) |
88,359 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Development and Chi |
• – – |
2011-05-26 |
4 |
AS |
$19.20 |
$3,667 |
D/D |
(191) |
70,581 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Development and Chi |
• – – |
2012-02-28 |
4 |
AS |
$14.90 |
$2,846 |
D/D |
(191) |
79,192 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Development and Chi |
• – – |
2010-05-26 |
4 |
AS |
$12.45 |
$2,390 |
D/D |
(192) |
18,032 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Development and Chi |
• – – |
2010-08-26 |
4 |
AS |
$16.57 |
$3,181 |
D/D |
(192) |
17,840 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Development and Chi |
• – – |
2010-11-29 |
4 |
AS |
$15.22 |
$2,922 |
D/D |
(192) |
17,648 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Development and Chi |
• – – |
2011-02-28 |
4 |
AS |
$13.85 |
$2,659 |
D/D |
(192) |
25,966 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Development and Chi |
• – – |
2011-11-28 |
4 |
AS |
$14.97 |
$2,874 |
D/D |
(192) |
69,809 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Development and Chi |
• – – |
2012-05-21 |
4 |
AS |
$13.87 |
$2,663 |
D/D |
(192) |
79,000 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Development and Chi |
• – – |
2012-05-29 |
4 |
AS |
$13.93 |
$2,675 |
D/D |
(192) |
78,619 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Development and Chi |
• – – |
2012-08-28 |
4 |
AS |
$14.35 |
$2,755 |
D/D |
(192) |
78,047 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Development and Chi |
• – – |
2012-11-27 |
4 |
AS |
$10.53 |
$2,022 |
D/D |
(192) |
77,474 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Development and Chi |
• – – |
2013-02-26 |
4 |
AS |
$12.58 |
$2,415 |
D/D |
(192) |
88,167 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Development and Chi |
• – – |
2013-08-23 |
4 |
AS |
$14.90 |
$2,861 |
D/D |
(192) |
86,951 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Development and Chi |
• – – |
2013-11-25 |
4 |
AS |
$17.77 |
$3,412 |
D/D |
(192) |
86,345 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Development and Chi |
• – – |
2014-02-25 |
4 |
AS |
$17.47 |
$3,354 |
D/D |
(192) |
105,022 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Development and Chi |
• – – |
2014-05-23 |
4 |
AS |
$12.09 |
$2,321 |
D/D |
(192) |
103,679 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Development and Chi |
• – – |
2014-08-25 |
4 |
AS |
$11.45 |
$2,198 |
D/D |
(192) |
102,821 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Development and Chi |
• – – |
2014-11-25 |
4 |
AS |
$11.67 |
$2,241 |
D/D |
(192) |
101,963 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Development and Chi |
• – – |
2015-02-24 |
4 |
AS |
$13.56 |
$2,604 |
D/D |
(192) |
120,155 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Development and Chi |
• – – |
2011-08-26 |
4 |
AS |
$16.07 |
$3,102 |
D/D |
(193) |
70,194 |
0 |
- |
|
97 Records found
|
|
Page 1 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
